Form D · Biotechnology
CoreBiome, Inc.
St. Paul, MN · CIK 0001710949
Offering snapshot reported Sep 12, 2018 · SEC filing
- Reported sold
- $550K Offering amount: $550K
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 29, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2018 | Initial | $550,000 | No comparison | 14 | SEC filing |
| Jul 5, 2017 | Initial | $800,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-321120
Series Seed Preferred Stock and Common Stock issuable upon conversion thereof.
Source: Form D, filed Sep 12, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Beckman | Director, Executive |
| Daryl Gohl | Director, Executive |
| Daniel Knights | Director, Executive, Promoter |
| Daniel Pomp | Director |
| Pamela York | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 Westgate Drive Lab 104
St. Paul, MN, 55114
St. Paul, MN, 55114